HSA Approval

RANFUZOSIN MODIFIED RELEASE TABLETS 10MG

Approval Number

SIN13984P

Drug Name

Product Name

RANFUZOSIN MODIFIED RELEASE TABLETS 10MG

Approval Date

July 5, 2011

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, EXTENDED RELEASE

Route of Administration

ORAL

Medical Information

ATC Code

G04CA01

ATC Item Name

alfuzosin

Manufacturer Information

Pharmaceutical Manufacturer

RANBAXY (MALAYSIA) SDN. BHD.

Manufacturers

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Active Ingredients

Ingredient Name

ALFUZOSIN HYDROCHLORIDE

Strength

10mg

Drug MonographAlfuzosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

RANFUZOSIN MODIFIED RELEASE TABLETS 10MG - HSA Approval | MedPath

AI-Powered Research

Premium Access

RANFUZOSIN MODIFIED RELEASE TABLETS 10MG

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal